<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Chemotherapy":2,
"Hypothyroidism":2,
"Malignancy":2,
"Optimal therapy":1,
"Review":1,
"BRAF kinase":1,
"Histiocytosis":1,
"Leukemia":2,
"V600E mutation":1,
"radioiodine therapy":1,
"salivary gland dysfunction":1,
"sialadenitis":1,
"thyroid cancer":13,
"xerostomia":2,
"hyperglycemia":1,
"hyperinsulinemia":1,
"insulin resistance":1,
"papillary thyroid cancer":7,
"esophageal invasion":1,
"functional outcomes":1,
"laryngeal invasion":1,
"tracheal invasion":1,
"Cell block":1,
"fine needle aspiration cytology":1,
"immunohistochemistry":8,
"intrathyroidal metastasis":1,
"BRAFV600E mutation":2,
"Hashimoto's thyroiditis":1,
"aggressiveness":1,
"stage":1,
"airway obstruction":1,
"anaplastic thyroid cancer":2,
"stridor":1,
"tracheotomy":1,
"PTTG1IP":1,
"TP53":1,
"colon":1,
"colorectal tumorigenesis":1,
"oncogene":1,
"Apoptosis":2,
"Cell cycle":1,
"Medullary thyroid cancer":1,
"cAMP analogs":1,
"cAMP-dependent protein kinase A (PKA) pathway":1,
"Endoscopic thyroidectomy":1,
"Minimally invasive surgery":1,
"Modified facelift approach":1,
"Remote access":1,
"Retroauricular approach":1,
"mandibular tumors":1,
"maxillary tumors":1,
"odontogenic fibromyxoma":1,
"odontogenic myxoma":1,
"pediatric tumors":1,
"Fordyce granules":1,
"Muir-Torre syndrome":1,
"intraoral":1,
"oral metastases":1,
"sebaceous carcinoma":1,
"Core-needle biopsy":1,
"Fine-needle aspiration":3,
"Thyroid carcinoma":4,
"Thyroid nodule":5,
"Ultrasound":3,
"Ectopic thyroid":1,
"Lingual thyroid":1,
"Lingual thyroid carcinoma":1,
"Incomplete response":1,
"Predictors":1,
"Minimally invasive follicular carcinoma":1,
"RAI":1,
"Surgery":2,
"Thyroid":6,
"Colorectal neoplasms":1,
"Mediator complex subunit 1":1,
"PPARγ":1,
"Carcinoma tiroideo":1,
"End-stage renal disease":2,
"Haemodialysis":1,
"Hemodiálisis":1,
"Insuficiencia renal terminal":1,
"Kidney transplantation":1,
"Radioiodine":3,
"Radioyodo":1,
"Trasplante renal":1,
"ImageStreamX imaging flow cytometry":1,
"circulating tumour cells":1,
"hepatocellular carcinoma":1,
"oesophageal adenocarcinoma":1,
"ovarian cancer":2,
"EPIC":1,
"differentiated thyroid carcinomas":1,
"glycemic index":1,
"macronutrients":1,
"total energy":1,
"2-Methoxyestradiol":1,
"Cabozantinib":1,
"Hypoxia-inducible factor":1,
"Medullary thyroid carcinoma":3,
"Signal transduction pathway":1,
"N-cadherin":1,
"Papillary thyroid carcinoma":8,
"Snail":1,
"BRAF":2,
"CD117":1,
"Immunocytochemistry":1,
"CDC20":1,
"Carcinomas":1,
"Normal/non-neoplastic tissues":1,
"hemodialysis":1,
"Genetic phenotype":1,
"Lung adenocarcinoma":1,
"Mucin-producing adenocarcinoma":1,
"Pathological subtype":1,
"Survival":3,
"Cancer":5,
"Germline mutation":1,
"RET proto-oncogene":1,
"Mutation":1,
"RAS":1,
"RET/PTC":1,
"Forkhead box P3":1,
"Sodium iodine symporter":1,
"TGF-β1":1,
"Single-nucleotide polymorphism":1,
"X-ray repair cross-complementing group 3":1,
"DICER1":1,
"MiRNA":1,
"Sarcoma":1,
"Sertoli-Leydig cell tumor":1,
"Antisense-miR-21":1,
"Cancer stem cell":1,
"Differentiation":1,
"Biopsy, fine-needle":2,
"Carcinoma, papillary":1,
"Carcinoma, papillary, follicular":1,
"Thyroid gland":3,
"Ultrasonography":2,
"Meta-analysis":3,
"Systemic lupus erythematosus":1,
"Cancer incidence rate":1,
"Nuclear power plants":2,
"14q32 deletion":1,
"DIO3":1,
"DLK1":1,
"Temple syndrome":1,
"YY1":1,
"Breast cancer":3,
"CtBP1":1,
"EMT":1,
"Metastasis":7,
"miR-137":1,
"DNA mutational analysis":1,
"fine-needle aspiration biopsy":1,
"high-throughput nucleotide sequencing":1,
"microarray analysis":1,
"molecular diagnostic techniques":1,
"thyroid neoplasms":2,
"PAX8":1,
"PNET":1,
"Renal PNET":1,
"multimorbidity":1,
"restless legs syndrome":1,
"risk alleles":1,
"Diagnosis":3,
"Elastography":1,
"Inter-observer variability":1,
"cytology":3,
"fine needle aspiration":2,
"microcalcifications":1,
"GPCR":1,
"adrenal cortex":1,
"cyclic AMP":1,
"gonad":1,
"neonate":1,
"parathyroid":1,
"proliferation":2,
"signal transduction":1,
"FTO":1,
"IVSA1-27777C&gt":1,
"A":1,
"Polymorphism":2,
"rs8050136":1,
"adolescents and young adults":1,
"late effects":1,
"pediatric oncology":1,
"radiation":1,
"second malignant neoplasms":1,
"fibroblast growth factor 19":1,
"motility":1,
"small interfering RNA":1,
"Acute":1,
"Myeloid":1,
"Radiation-induced":1,
"Radioisotopes":2,
"Cancer biomarker":1,
"Cancer invasion":1,
"Extracellular vesicles":1,
"Integrin-FAK signaling":1,
"Alpha lipoic acid":1,
"Epithelial–mesenchymal transition":1,
"Transforming growth factor beta":1,
"FNA":1,
"calcitonin":1,
"washout":1,
"TROP-2":1,
"124I PET/CT":1,
"131I SPECT/CT":1,
"detectability":1,
"phantom":1,
"Cervical metastasis":1,
"Node metastatic pattern":1,
"Aneuploidy":1,
"Bisphenol A":1,
"Endocrine disruptors":1,
"Environment":1,
"Estrogens":1,
"Neoplasm":2,
"Steroids":1,
"Systematic review":1,
"postoperative nonstimulated thyroglobulin":1,
"recurrence":1,
"bilaterality":1,
"lymph node metastasis":1,
"multifocality":1,
"Atypia of undetermined significance":1,
"Bethesda III category":1,
"Factors to triage to thyroid surgery":1,
"Predictive factors for thyroid malignancy":1,
"Selection of nodules for thyroid surgery":1,
"JAK2-STAT3 signaling":1,
"Pten-deficiency":1,
"STAT3 inhibitor":1,
"obesity":2,
"preclinical mouse model":1,
"thyroid hormone receptor β mutant":1,
"BRAF mutation":2,
"central lymph node metastasis":1,
"chronic lymphocytic thyroiditis":1,
"extrathyroidal extension":1,
"Head and neck cancer":1,
"Head and neck surgery":1,
"Neck dissection":1,
"Nodal yield":1,
"Robotic surgery":1,
"ALK":1,
"Crizotinib":1,
"Lung cancer":1,
"Squamous cell carcinoma":1,
"Afirma":1,
"Bethesda classification":1,
"Genetic testing":1,
"Molecular markers":1,
"Thyroid nodules":2,
"Central neck lymph node dissection":1,
"Lymph node dissection":1,
"Lymph node metastases":1,
"Recurrent thyroid cancer":1,
"I(131)":1,
"Radioactive iodine":1,
"TSH suppression":1,
"Adrenal":1,
"Hemoperitoneum":1,
"Multiple endocrine neoplasia":1,
"Pheochromocytoma":1,
"anticoagulation":1,
"head and neck ultrasound":1,
"thyroid fine-needle aspiration":1,
"Papillary thyroid carcinoma (PTC)":1,
"Right paraesophageal lymph node (RPELN)":1,
"chemokine":1,
"innate immunity":1,
"tumor vasculature":1,
"tumor-associated macrophages":1,
"virotherapy":1,
"outcome":1,
"prognosis":1,
"risk stratification":1,
"Akt1":1,
"Invasion":1,
"miR-409-3p":1,
"Hypercalcaemia":1,
"Parathyroid hormone":1,
"Parathyroidectomy":1,
"Primary hyperparathyroidism":1,
"Thyroid disease":1,
"KSR1":1,
"chemosensitivity":1,
"colorectal cancer":1,
"miR-497":1,
"tumorigenesis":1,
"Iodine radioisotopes":1,
"Molecular targeted therapy":1,
"Survival analysis":1,
"Thyroglobulin":2,
"Thyroid neoplasm":1,
"Advanced":1,
"Differentiated":1,
"Medullary":1,
"Multikinase":1,
"Refractory":1,
"carcinoma of unknown primary (CUP)":1,
"circulating tumor cells (CTCs)":1,
"immunofluorescence":1,
"Nrf2":1,
"ORP150":1,
"proteasome inhibitor":1,
"BRD4":1,
"C-MYC":1,
"JQ1":1,
"NIS":1,
"assays":1,
"biomarker":2,
"differentiated thyroid cancers":1,
"Colorectal carcinoma":1,
"Melanoma":1,
"NRAS":1,
"nuclear corepressor 1":1,
"thyroid hormone receptor":1,
"transcription":1,
"tumor growth":1,
"Hip":1,
"Metal-on-metal":1,
"cobalt":1,
"tociity":1,
"Diffusion-weighted imaging":1,
"benign thyroid diseases":1,
"changes of radioiodine therapy":1,
"jóindulatú pajzsmirigybetegségek":1,
"pajzsmirigyrák":1,
"radiojódterápia változásai":1,
"atypia of undetermined significance (AUS)":1,
"quality":1,
"repeat fine-needle aspiration (FNA)":1,
"Metabolic syndrome":1,
"Head and neck neoplasms":1,
"Microbiology":1,
"Surgical site infection":1,
"Diet":1,
"Radioactivity":1,
"Radionuclide":1,
"Risk Assessment":1,
"Akt/PKB kinases":1,
"adrenocortical carcinoma":1,
"gastroenteropancreatic neuroendocrine tumors":1,
"neuroblastoma":1,
"parathyroid tumors":1,
"phaeochromocytoma":1,
"pituitary tumors":1,
"thyroid tumors":1,
"DNA methylation":1,
"Discordant monozygotic twins":1,
"Epigenetics":1,
"Twin study":1,
"Follicular Thyroid Carcinoma":1,
"Free Tissue Flaps":1,
"Mediastinum":1,
"immunomarker":1,
"thyroid lesions":1,
"Maternal mortality":1,
"Neoplasms":1,
"Pregnancy":1,
"Pregnancy outcome":1,
"differentially-expressed gene":1,
"modules":1,
"chromosome rearrangement":1,
"chronic myelomonocytic leukemia":1,
"gene fusion":1,
"platelet-derived growth factor receptor β":1,
"Differentiated thyroid cancer":1,
"Follicular thyroid cancer":1,
"Spine":1,
"Vertebrae":1,
"clinicopathogical":1,
"primary lung intestinal adenocarcinoma":1,
"Radionuclide imaging":1,
"131I":1,
"brain":1,
"hemimegalencephaly":1,
"renal":1,
"single photon emission computed tomography-computed tomography":1,
"thyroid cancerhemihypoperfusion":1,
"Hypofractionated radiotherapy":1,
"intensity modulated radiotherapy":1,
"melanotic medullary carcinoma thyroid":1,
"tumor thrombus":1,
"Spain":1,
"adolescents":1,
"childhood":1,
"incidence":1,
"population-based study":1,
"solid tumour":1,
"Eosinophilia":1,
"sclerosing mucoepidermoid carcinoma":1,
"Papillary carcinoma":2,
"Sistrunk operation":1,
"thyroglossal duct":1,
"AXIN2":1,
"Papillary":1,
"Single Nucleotide":1,
"Dual malignancies":1,
"metachronous malignancy":1,
"multiple primary cancers":1,
"synchronous malignancy":1,
"fibrous dysplasia":1,
"monostotic":1,
"spinal cord compression":1,
"thoracic vertebra":1,
"antioxidants":1,
"malondialdehyde":1,
"protein carbonyl":1,
"superoxide dismutase":1,
"Good outcome":1,
"Ibadan":1,
"Nigeria":1,
"Retrosternal goitre":1,
"Sternotomy":1,
"Total thyroidectomy":1,
"Bamako":1,
"CHU du Point G":1,
"Point G University Hospital":1,
"chirurgie":1,
"goiter":1,
"goitre":1,
"cardiovascular risk":1,
"differentiated thyroid carcinoma":1,
"hsCRP":1,
"myocardial perfusion":1,
"thyroid hormone withdrawal":1,
"occult carcinoma":1,
"papillary micro-carcinoma":1,
"clear cell renal carcinoma":1,
"thyroid secondary neoplasm":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2016年1月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
